analyst
PH
NASDAQ · PHAT
Phathom Pharmaceuticals, Inc.
Healthcare · Biotechnology
$8.16
Down-$0.47 (-5.76%)
Updated Sep 16, 2026, 10:35 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.04B
- P/E ratio
- -3.89
- Dividend yield
- 0.00%
- 52-week range
- $8.07 – $18.31
- Volume
- 1.64M
- Avg. volume
- 1.06M
Price performance
PHAT price history
1M range · 20 trading sessions · Daily adjusted prices
PHAT closed at $8.16 after 20 trading sessions, down 11.78% for the selected period.
- Last close
- $8.16
- Period change
- -11.78%
- Period low
- $8.16
- Period high
- $9.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $8.63 | $8.655 | $8.10 | $8.16 | 1.64M |
| Sep 14, 2026 | $8.45 | $8.8299 | $8.35 | $8.68 | 1.32M |
| Sep 11, 2026 | $8.40 | $8.52 | $8.07 | $8.36 | 1.39M |
| Sep 10, 2026 | $8.50 | $8.545 | $8.29 | $8.37 | 1.09M |
| Sep 9, 2026 | $9.32 | $9.32 | $8.64 | $8.67 | 1.11M |
| Sep 8, 2026 | $9.42 | $9.65 | $9.22 | $9.43 | 1.03M |
| Sep 4, 2026 | $8.99 | $9.55 | $8.8901 | $9.50 | 1.24M |
| Sep 3, 2026 | $9.30 | $9.3113 | $8.984 | $9.05 | 663.06K |
| Sep 2, 2026 | $9.45 | $9.7296 | $9.05 | $9.26 | 932.65K |
| Sep 1, 2026 | $9.55 | $9.675 | $9.15 | $9.39 | 885.49K |
| Aug 31, 2026 | $9.17 | $9.695 | $9.0401 | $9.57 | 1.21M |
| Aug 28, 2026 | $8.89 | $9.305 | $8.7816 | $9.18 | 894.43K |
| Aug 27, 2026 | $8.77 | $8.99 | $8.545 | $8.94 | 1.05M |
| Aug 26, 2026 | $8.78 | $8.865 | $8.571 | $8.77 | 800.62K |
| Aug 25, 2026 | $8.75 | $8.94 | $8.64 | $8.80 | 748.61K |
| Aug 24, 2026 | $8.88 | $8.92 | $8.51 | $8.66 | 992.81K |
| Aug 21, 2026 | $8.63 | $8.896 | $8.59 | $8.87 | 979.41K |
| Aug 20, 2026 | $9.25 | $9.30 | $8.40 | $8.60 | 1.41M |
| Aug 19, 2026 | $9.42 | $9.70 | $9.31 | $9.32 | 781.95K |
| Aug 18, 2026 | $9.33 | $9.745 | $9.175 | $9.25 | 976.46K |
Latest PHAT news
The latest Smart Investors Daily articles mentioning PHAT.
Stock researchMarket Activity · Short Interest
Loading stock research…